The Pharmaceutical Industry — Prices and Progress

Published on Aug 26, 2004in The New England Journal of Medicine70.67
· DOI :10.1056/NEJMhpr040117
F. M. Scherer45
Estimated H-index: 45
In this Health Policy Report, the author examines the economics of the pharmaceutical industry. Research-and-development costs, patent laws, and health insurance coverage all influence drug pricing. The author discusses the policy dilemmas resulting from the complex economics of pharmaceutical research and development and reviews potential strategies to control prices.
  • References (17)
  • Citations (99)
#1Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
#2Ronald W. Hansen (UR: University of Rochester)H-Index: 7
Last.Henry G. Grabowski (Duke University)H-Index: 39
view all 3 authors...
#1Kenneth I. Kaitin (Tufts Center for the Study of Drug Development)H-Index: 23
#2Joseph A. DiMasi (Tufts Center for the Study of Drug Development)H-Index: 26
#1Wesley M. Cohen (Duke University)H-Index: 33
#2Richard R. Nelson (Columbia University)H-Index: 84
Last.John Walsii (UIC: University of Illinois at Chicago)H-Index: 28
view all 3 authors...
Cited By99
#1Kiu Tay-Teo (WHO: World Health Organization)H-Index: 1
#2André Ilbawi (WHO: World Health Organization)H-Index: 2
Last.Suzanne Hill (WHO: World Health Organization)H-Index: 29
view all 3 authors...
#1Rafael Fonseca (Mayo Clinic)H-Index: 91
#2Desi Peneva (Precision Health Economics)H-Index: 6
Last.Anupam B. Jena (Harvard University)H-Index: 29
view all 5 authors...
#1Omid Moshtaghi (UCI: University of California, Irvine)H-Index: 6
#2Yarah M. Haidar (UCI: University of California, Irvine)H-Index: 6
Last.Hamid R. Djalilian (UCI: University of California, Irvine)H-Index: 20
view all 9 authors...
#1Anna Wolters (UM: Maastricht University)H-Index: 2
#2Guido de Wert (UM: Maastricht University)H-Index: 24
Last.Klasien Horstman (UM: Maastricht University)H-Index: 12
view all 4 authors...
View next paperPharmaceutical Price Controls and Entry Strategies